Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Mar 21, 2020; 26(11): 1185-1196
Published online Mar 21, 2020. doi: 10.3748/wjg.v26.i11.1185
Table 1 Correlation between preoperative albumin and clinicopathologic variables in patients undergoing gastrointestinal surgery
CharacteristicsTotal cohort
Subgroups of preoperative albumin
P value
n = 311< 39.15, n = 135≥ 39.15, n = 176
Sex0.364
Female93 (29.90%)44 (32.59%)49 (27.84%)
Male218 (70.10%)91 (67.41%)127 (72.16%)
Age (yr)58.98 ± 10.9860.52 ± 10.7757.80 ± 11.030.030
Categorical variable0.007
< 60156 (50.16%)56 (41.48%)100 (56.82%)
≥ 60155 (49.84%)79 (58.52%)76 (43.18%)
Body mass index (kg/m2)24.43 ± 3.2324.14 ± 3.1124.65 ± 3.310.173
Categorical variable0.136
< 25174 (55.95%)82 (60.74%)92 (52.27%)
≥ 25137 (44.05%)53 (39.26%)84 (47.73%)
Previous abdominal surgery0.178
No252 (81.03%)114 (84.44%)138 (78.41%)
Yes59 (18.97%)21 (15.56%)38 (21.59%)
Preoperative albumin (g/L)39.77 ± 3.6736.46 ± 2.3342.30 ± 2.19< 0.001
Preoperative K+ (mmol/L)3.96 ± 0.323.94 ± 0.343.98 ± 0.310.306
Categorical variable0.948
< 3.96155 (49.84%)67 (49.63%)88 (50.00%)
≥ 3.96156 (50.16%)68 (50.37%)88 (50.00%)
Type of cancer0.701
Gastric cancer162 (52.09%)72 (53.33%)90 (51.14%)
Colorectal cancer149 (47.91%)63 (46.67%)86 (48.86%)
Surgical technique0.868
Endoscopic surgery215 (69.13%)94 (69.63%)121 (68.75%)
Open surgery96 (30.87%)41 (30.37%)55 (31.25%)
Tumor stage0.094
I-II133 (43.46%)65 (48.87%)68 (39.31%)
III-IV173 (56.54%)68 (51.13%)105 (60.69%)
Postoperative opioid analgesic0.983
No191 (61.41%)83 (61.48%)108 (61.36%)
Yes120 (38.59%)52 (38.52%)68 (38.64%)
PPOI0.028
No244 (78.46%)98 (72.59%)146 (82.95%)
Yes67 (21.54%)37 (27.41%)30 (17.05%)
Table 2 Univariate analysis of the potential clinicopathologic variables of Prolonged postoperative ileus
CharacteristicsWithout PPOI
With PPOI
Univariate
P value
(n = 244)(n = 67)OR (95%CI)
Sex0.362
Female76 (81.72%)17 (18.28%)Ref.
Male168 (77.06%)50 (22.97%)1.33 (0.72, 2.46)
Age (yr)0.867
< 60123 (78.58%)33 (21.15%)Ref.
≥ 60121 (78.06%)34 (21.94%)1.05 (0.61, 1.80)
Body mass index (kg/m2)0.886
< 25136 (78.16%)38 (21.84%)Ref.
≥ 25108 (78.83%)29 (21.17%)0.96 (0.56, 1.66)
Previous abdominal surgery0.803
No197 (78.17%)55 (21.83%)Ref.
Yes47 (79.66%)12 (20.34%)0.91 (0.45, 1.84)
Preoperative albumin (g/L)0.029
< 39.1598 (72.59%)37 (27.41%)Ref.
≥ 39.15146 (82.95%)30 (17.05%)0.54 (0.32, 0.94)
Preoperative K+ (mmol/L)0.701
< 3.96123 (79.35%)32 (20.65%)Ref.
≥ 3.96121 (77.56%)35 (22.44%)1.11 (0.65, 1.91)
Type of cancer0.424
Gastric cancer130 (80.25%)32 (19.75%)Ref.
Colorectal cancer114 (76.51%)35 (23.49%)1.25 (0.73, 2.14)
Surgical technique0.839
Endoscopic surgery168 (78.14%)47 (21.86%)Ref.
Open surgery76 (79.17%)20 (20.83%)0.94 (0.52, 1.70)
Tumor stage< 0.001
I-II118 (88.72%)15 (11.28%)Ref.
III-IV121 (69.94%)52 (30.06%)3.33 (1.81, 6.25)
Postoperative opioid analgesic< 0.001
No164 (85.86%)27 (14.14%)Ref.
Yes80 (66.67%)40 (33.33%)3.04 (1.74, 5.30)
Table 3 Association between perioperative albumin and prolonged postoperative ileus by multiple regression analysis in different models
Models
Crude model
P valueModel I
P valueModel II
P value
Preoperative albumin (g/L)OR (95%CI)OR (95%CI)OR (95%CI)
Continuous variable
Per unit0.95 (0.88, 1.02)0.1740.95 (0.88, 1.02)0.1550.92 (0.85, 1.00)0.046
Per SD (3.67)0.83 (0.63, 1.09)0.1740.82 (0.62, 1.08)0.1550.73 (0.54, 0.99)0.046
Categorical variable
< 39.15Ref.Ref.Ref.
≥ 39.150.54 (0.32, 0.94)0.0290.53 (0.31, 0.92)0.0250.43 (0.24, 0.78)0.006